Facebook      Twitter




HIV and Oral Healthcare (14HC02)

Cheryl R. Stolarski, DMD

  Release Date: December 1, 2011
EXPIRED: November 30, 2013
Activity Code: 14HC02

This content is being provided for informational purposes only.

As seen in the December 2011 edition of



Sponsored by the University of Medicine & Dentistry of New Jersey (UMDNJ), Center for Continuing & Outreach Education (CCOE), Division of AIDS Education.


This activity is supported by an educational grant from the New Jersey Department of Health and Senior Services (NJDHSS) - Division of HIV, STD and TB Services, through an MOA titled “Education and Training for Physicians and other Healthcare Professionals in the Diagnosis and Treatment of HIV/AIDS.” The New York/New Jersey AETC (AIDS Education and Training Center (NY/NJAETC) provided in-kind support through the work of its Dental Co-Director, Cheryl R. Stolarski, DMD.

Target Audience

This free knowledge-based activity is designed for physicians, nurses, pharmacists, social workers, dentists, dental hygienists and other health care professionals in New Jersey who are involved in the care of persons with HIV/AIDS and/or hepatitis.

Statement of Need

Oral diseases associated with HIV infection include oral candidiasis and Kaposi’s sarcoma, which are indicators included in the diagnostic definition of AIDS, and oral cancer. These conditions have become less common since the advent of HAART in 1996. However, HIV/AIDS patients with uncontrolled viral loads, indicating immunocompromise, continue to present to both dentists and other healthcare professionals with ulceration of the oral cavity and other, often-painful, symptoms. These patients may not be in routine dental care, and all healthcare providers seeing HIV patients should be able to identify oral manifestations and provide emergency care as well as facilitating access to dental providers for necessary treatment. Oral disease is indicative of systemic inflammatory processes which may exacerbate chronic infections including HIV and hepatitis.

The USDHSS-HRSA-HIV/AIDS Bureau has added routine oral screening to the quality benchmarks of HIV care that should be provided to all individuals with HIV/AIDS. They note that “when the oral cavity is compromised by the presence of pain or discomfort, maintaining adherence to complicated antiretroviral therapy regimens becomes more difficult.”

Learning Objectives

Upon completion of this activity, participants should be able to:

  1. Identify the impact of oral disease on systemic health of HIV/AIDS patients, and symptoms of disease including oral lesions.
  2. Implement oral health screening, as part of the overall healthcare plan.
  3. Distinguish and differentiate the need for emergency dental care due to acute infection, pathology or pain. Prescribe analgesics and antibiotics when appropriate and facilitate access to a dental provider for follow up treatment.


Activity Director(s)/CME Academic Advisor(s)

Patricia Kloser, MD, MPH, Professor of Medicine, UMDNJ-New Jersey Medical School and UMDNJ-School of Public Health.

Planning Committee

Sindy Paul, MD, MPH, FACPM, Medical Director, Division of HIV, STD and TB Services, New Jersey Department of Health and Senior Services.

Debbie Y. Mohammed, MS, MPH, APRN-BC, ACRN, Nurse Practitioner, UMDNJ-University Hospital and St.Michael’s Medical Center – Peter Ho Clinic.

Humberto Jimenez, PharmD, AAHIVE, Infectious Disease Pharmacist, St.Michael’s Medical Center; Clinical Assistant Professor, Ernest Mario School of Pharmacy, Rutgers University.

Kimi Nakata, MSW, MPH, UMDNJ-CCOE-Division of AIDS Education Program Supervisor and Editor, NJ AIDSLine.

Bonnie R. Abedini, MSN, RN, Director, Quality & Compliance, Rutgers University Health Services.


Cheryl R. Stolarski, DMD - Dental Co-Director, NY/NJ AIDS Education & Training Centers; AIDS Institute – Office of the Medical Director.

Mahnaz Fatahzadeh, BSc, DMD, MSD, Dip ABOM - Associate Professor, Department of Diagnostic Science, Division of Oral Medicine, New Jersey Dental School, UMDNJ.

Method of Instruction

Participants should read the learning objectives, review the activity in its entirety, and then complete the self-assessment test which consists of a series of multiple-choice questions. Upon completing this activity as designed, achieving a passing score of 70% or more on the self-assessment test and submitting a course evaluation, participants will have access to an online printable credit statement. Estimated time to complete this activity as designed is 1.32 hours for nurses, and 1.0 hours for physicians, pharmacists, dentists and dental hygienists.


Credit is no longer available for this activity.


In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, UMDNJ-CCOE has resolved all potential and real conflicts of interest through content review by non-conflicted, qualified reviewers. This activity was peer-reviewed for relevance, accuracy of content and balance of presentation by Patricia Kloser, MD, MPH; Debbie Mohammed, MS, MPH, APRN-BC, AACRN; Humberto Jimenez, BCPS, PharmD, AAHIVE, Brenda Christian, MEd, PA-C; Director of AIDS Education, UMDNJ-CCOE.

Field Test:
This activity was pilot-tested for time required for participation by Kinshasa Morton, MD; Shobha Swaminathan, MD; Jojy Cheriyan, MD; Mary C. Krug, MSN, APN; Renee Powell, BS, RN; Kara Winslow, BSN, RN; Polly Jen, PharmD; John Faragon, PharmD, AAHIVE; and George Rusuloj, PharmD.

Disclosure Disclaimer

In accordance with the disclosure policies of UMDNJ and to conform with ACCME and FDA guidelines, individuals in a position to control the content of this educational activity are required to disclose to the activity participants: 1) the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 12 months; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/ device not yet approved.

Faculty Disclosure Declarations

There were no relevant financial relationships to disclose reported by the activity director, faculty, planning committee members, peer reviewers or field testers.

Off-Label Usage Disclosure

This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.

Content Disclaimer

The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of NNDHSS - Division of HIV, STD and TB Services, any manufacturer of pharmaceuticals or devices, or UMDNJ. It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Copyright © 2011 UMDNJ-Center for Continuing and Outreach Education. All rights reserved including translation into other languages.No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from UMDNJ-Center for Continuing and Outreach Education. Please direct CME related questions to UMDNJ at 973-972-4267 or email ccoe@ca.rutgers.edu.


© Copyright 2020, Rutgers, The State University of New Jersey, an equal opportunity, affirmative action institution.

Privacy Policy